Study IDs Downstream Procedure, Complication Rates After Lung Cancer Screening

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

TUESDAY, Jan. 2, 2024 -- For individuals undergoing low-dose computed tomography (LDCT) scans for lung cancer screening (LCS), the rates of downstream procedures and complications are higher than observed in the National Lung Screening Trial (NLST), according to a study published online Jan. 2 in the Annals of Internal Medicine.

Katharine A. Rendle, Ph.D., M.P.H., from the Perelman School of Medicine at the University of Pennsylvania in Philadelphia, and colleagues conducted a retrospective cohort study to identify rates of downstream procedures and complications associated with LCS in five U.S. health care systems. Data were included for 9,266 patients who completed a baseline LDCT scan for LCS between 2014 and 2018.

The researchers found that 15.9 percent of the patients had a baseline LDCT scan showing abnormalities, and of these patients, 9.5 percent were diagnosed with lung cancer within 12 months (positive predictive value, 9.5 percent; negative predictive value, 99.8 percent; sensitivity, 92.7 percent; specificity, 84.4 percent). In screened patients, absolute rates of downstream imaging and invasive procedures were 31.9 and 2.8 percent, respectively. Complication rates were substantially higher for those undergoing invasive procedures after abnormal findings than those in the NLST (30.6 versus 17.7 percent for any complication; 20.6 versus 9.4 percent for major complications).

"We observed higher rates of both invasive procedures and complications than those observed in NLST, highlighting the need for practice-based strategies to assess variations in the quality of care and to prioritize LCS among those patients most likely to receive a net benefit from screening in relation to potential complications and other harms," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-01-03 00:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords